Latest Posts
April 15, 2026
In Sequence: The Unseen Commitment to Quality at MicroGenDX When you receive your test results from MicroGenDX, you are seeing the final product of a comprehensive lab quality journey that began long before your sample arrived at our laboratory. What you don’t see are the countless hours of validation, the daily quality checks, the rigorous training programs, and the unwavering commitment to accuracy that happens behind our laboratory doors. Let’s pull back the curtain and show you what really goes on in our lab. The Foundation: Test Validation and Development Before any of our tests are approved for real world […]
March 30, 2026
Understanding the gap between clinical necessity and insurance coverage — and how your billing team can help close it. The Test Was Right. The Claim Was Denied. You ordered a molecular diagnostic test because culture alone wasn’t giving you the answer you needed. The clinical rationale was sound. The result informed your treatment plan. And then the claim came back denied. This scenario is more common than it should be — and it rarely has anything to do with whether the test was medically necessary. More often, the denial stems from a mismatch between how the encounter was documented and […]
March 4, 2026
A Paradigm Shift in Urology For much of modern medicine, a foundational assumption shaped the way clinicians approached urinary tract health: healthy urine is sterile. That assumption influenced how specimens were cultured, how infections were diagnosed, and how treatment decisions were made. It also meant that any bacterium detected in urine was presumed to be either a contaminant or a pathogen- with little consideration for a middle ground. Over the past decade, advances in molecular sequencing have dismantled this paradigm. Culture-independent techniques, particularly 16S ribosomal RNA (rRNA) gene sequencing, have revealed that the human urinary tract harbors a resident […]
January 27, 2026
DON’T PANIC The Clinician’s Guide to the Genomic Galaxy is designed to help you navigate the genomic landscape that is materializing beneath your feet as we speak. It is materializing quickly; we should learn to walk now so that we may run in the days ahead. When clinicians first encounter next-generation sequencing (NGS), or hear it discussed at conferences, the road is difficult to see through all the caution signs and while caution is certainly appropriate, these signs are often treated like “road closed” signs. Some of the cautionary statements that frequent discussions of molecular diagnostics are: NGS is too […]
January 23, 2026
A Structural Shift in Outpatient Orthopedics – and the Role of Diagnostics Beginning January 1, 2026, a fundamental shift will take place in outpatient orthopedic care. The Centers for Medicare & Medicaid Services (CMS) has finalized a rule expanding Ambulatory Surgical Center (ASC) eligibility to include select revision total knee and hip arthroplasty procedures. This decision moves some of the most complex orthopedic cases into outpatient settings for appropriately selected patients. While this policy change expands access and efficiency, it also raises the bar for diagnostic certainty. Revision arthroplasty carries inherently higher clinical risk-particularly related to occult infection-and the ASC environment allows far less tolerance for […]